Following our findings that DMF and 4-OI block the induction and release of TF in response to LPS, thereby blocking thrombin generation in vitro, we next investigated the effects of DMF and 4-OI in vivo in a systemic model of LPS-induced inflammation and coagulopathy. The gene discussed is TF; the disease is blood coagulation disease.